Ubs Group Ag Lannett CO Inc Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$0.45 - $0.86 $2,819 - $5,388
6,266 Added 610.72%
7,292 $3,000
Q3 2022

Nov 10, 2022
SELL
$0.46 - $0.63 $5,119 - $7,011
-11,130 Reduced 91.56%
1,026 $0
Q2 2022

Aug 10, 2022
BUY
$0.47 - $0.87 $3,643 - $6,745
7,753 Added 176.08%
12,156 $7,000
Q1 2022

May 16, 2022
SELL
$0.75 - $1.77 $28,227 - $66,615
-37,636 Reduced 89.53%
4,403 $3,000
Q4 2021

Feb 14, 2022
BUY
$1.56 - $2.93 $63,637 - $119,523
40,793 Added 3273.92%
42,039 $68,000
Q3 2021

Nov 15, 2021
BUY
$2.91 - $4.83 $2,723 - $4,520
936 Added 301.94%
1,246 $4,000
Q2 2021

Aug 13, 2021
SELL
$4.17 - $5.74 $67,579 - $93,022
-16,206 Reduced 98.12%
310 $1,000
Q1 2021

May 12, 2021
SELL
$5.28 - $9.64 $54,922 - $100,275
-10,402 Reduced 38.64%
16,516 $87,000
Q4 2020

Feb 11, 2021
BUY
$5.75 - $7.13 $122,365 - $151,733
21,281 Added 377.52%
26,918 $175,000
Q3 2020

Nov 12, 2020
SELL
$4.9 - $7.12 $54,674 - $79,444
-11,158 Reduced 66.44%
5,637 $34,000
Q2 2020

Jul 31, 2020
SELL
$6.43 - $9.86 $35,191 - $53,963
-5,473 Reduced 24.58%
16,795 $122,000
Q1 2020

May 01, 2020
SELL
$6.36 - $10.05 $122,633 - $193,784
-19,282 Reduced 46.41%
22,268 $154,000
Q4 2019

Feb 14, 2020
BUY
$8.49 - $12.81 $239,171 - $360,870
28,171 Added 210.56%
41,550 $367,000
Q3 2019

Nov 14, 2019
BUY
$5.58 - $14.47 $20,623 - $53,481
3,696 Added 38.17%
13,379 $150,000
Q2 2019

Aug 14, 2019
BUY
$5.22 - $9.08 $38,393 - $66,783
7,355 Added 315.94%
9,683 $59,000
Q1 2019

May 14, 2019
SELL
$5.35 - $9.82 $66,671 - $122,376
-12,462 Reduced 84.26%
2,328 $18,000
Q4 2018

Feb 14, 2019
SELL
$3.43 - $6.19 $6,976 - $12,590
-2,034 Reduced 12.09%
14,790 $74,000
Q3 2018

Nov 14, 2018
BUY
$4.75 - $14.5 $15,608 - $47,647
3,286 Added 24.27%
16,824 $80,000
Q2 2018

Aug 14, 2018
SELL
$13.3 - $17.45 $64,611 - $84,772
-4,858 Reduced 26.41%
13,538 $184,000
Q1 2018

May 15, 2018
SELL
$14.7 - $24.95 $38,969 - $66,142
-2,651 Reduced 12.6%
18,396 $295,000
Q4 2017

Feb 14, 2018
SELL
$19.9 - $29.25 $580,204 - $852,813
-29,156 Reduced 58.08%
21,047 $489,000
Q3 2017

Nov 14, 2017
BUY
$15.1 - $19.25 $439,108 - $559,790
29,080 Added 137.67%
50,203 $926,000
Q2 2017

Aug 14, 2017
SELL
N/A
-2,111 Reduced 9.09%
21,123 $431,000
Q1 2017

Nov 14, 2017
BUY
N/A
23,234
23,234 $519,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About LANNETT CO INC

LCI Quotes by TradingView
  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email